Home - Products - Others - Other Targets - TFLLR-NH2 2TFA(197794-83-5(free base))

TFLLR-NH2 2TFA(197794-83-5(free base))

CAS No. ——

TFLLR-NH2 2TFA(197794-83-5(free base))( —— )

Catalog No. M22777 CAS No. ——

TFLLR-NH2(2TFA) is an agonist of PAR1 (EC50 :1.9 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 609 In Stock
10MG 1017 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TFLLR-NH2 2TFA(197794-83-5(free base))
  • Note
    Research use only, not for human use.
  • Brief Description
    TFLLR-NH2(2TFA) is an agonist of PAR1 (EC50 :1.9 μM).
  • Description
    TFLLR-NH2(2TFA) is an agonist of PAR1 (EC50 :1.9 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PAR1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    647.81
  • Molecular Formula
    C31H53N9O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)C(F)(F)F.CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kawabata A , Kuroda R , Kuroki N , et al. Characterization of the protease-activated receptor-1-mediated contraction and relaxation in the rat duodenal smooth muscle[J]. Life Sciences, 2000, 67(20):0-2530.
molnova catalog
related products
  • STF-118804

    STF-118804 is a highly specific NAMPT inhibitor; reduces the viability of most B-ALL cell lines with IC50 <10 nM.

  • ONO-RS-082

    ONO-RS-082 is a Ca2+-independent phospholipase A2 inhibitor.?

  • Astegolimab

    Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.